The use of separation techniques in the analysis of some antiepileptic drugs: A critical review

References

• Brayefireld, A. (Ed.) Martindale “The Complete Drug Reference”, 38th Ed.; Pharmaceutical Press: London, 2014; 526–562 pp.
   Google Scholar
• Brodie, M. J. Antiepileptic Drug Therapy the Story So Far. Seizure 2010, 19(10), 650–655.
   PubMed Web of Science ®Google Scholar
• Lemke, T. L. (Ed.) Foye’s Principles of Medicinal Chemistry, 7th Ed.; Lippincott Williams & Wilkins, A Wolters Kluwer Business: Philadelphia, 2013; 550–564 pp.
   Google Scholar
• Eslicarbazepine acetate | C17H16N2O3 – PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/Eslicarbazepine_acetate#section = Top (accessed May 3, 2016).
   Google Scholar
• May, T. W.; Merker, E. K.; Rambeck, B. Clinical Pharmacokinetics of Oxcarbazepine. Clin. Pharmacokinet. 2012, 42(12), 1023–1042.
   Web of Science ®Google Scholar
• Luszczki, J. J. Third-Generation Antiepileptic Drugs: Mechanisms of Action, Pharmacokinetics and Interactions. Pharmacol. Rep. 2009, 61(2), 197–216.
   PubMed Web of Science ®Google Scholar
• Patsalos, P. N. Clinical Pharmacokinetics of Levetiracetam. Clin. Pharmacokinet. 2012, 43(11), 707–724.
   Web of Science ®Google Scholar
• The British Pharmacopoeia; HM Stationary Office: London, 2013.
   Google Scholar
• The British Pharmacopoeia; HM Stationary Office: London, 2016; 89,90,465,466 pp.
   Google Scholar
• The European Pharmacopoeia, 8th Ed.; Council of Europe, 2016; 2604,2605,2931,5801,5802 pp.
   Google Scholar
• Valarmathi, R.; Banu, S. F.; Akilandeswari, S.; Senthamarai, R.; Dhivya, C. S. A Review on New Antiepileptic Drug – Lacosamide and its Analytical Methods. Int. J. Pharm. Chem. Sci. 2013, 2(1), 181–186.
   Google Scholar
• Kostić, N.; Dotsikas, Y.; Malenovic, A. Critical Review on the Analytical Methods for the Determination of Zwitterionic Antiepileptic Drugs_vigabatrin, Pregabalin, and Gabapentin_in Bulk and Formulations. Instrum. Sci. Technol. 2014, 42, 486–512.
   Web of Science ®Google Scholar
• Kamdar, S. A.; Vaghela, V. M.; Desai, P. A. Development and Validation of HPTLC Method for Estimation of Lacosamide in Bulk Drug and in Tablet Dosage Form. Int. J. ChemTech. Res. 2012, 4(3), 1193–1197.
   Google Scholar
• Patel, A.; Suhagia, B. N.; Patwari, A. Stability Indicating Assay Method for Quantification of Lacosamide in Bulk and its Pharmaceutical Dosage Form and Characterization of Major Degradation Products. Int. J. Pharm. Pharm. Sci. 2013, 6(1), 593–599.
   Google Scholar
• Reddy, T. S.; Devi, P. S. Validation of a High-Performance Thin-Layer Chromatographic Method with Densitometric Detection for Quantitative Analysis of Two Anticonvulsants in Tablets. J. planar Chromatogr. 2007, 20(6), 451–456.
   Web of Science ®Google Scholar
• Gandhi, S. V.; Kadam, A. A.; Karad, M. M. Development and Validation of Stability-Indicating HPTLC Method for Determination of Levetiracetam in Pharmaceutical Dosage Form. Int. J. Pharm. Pharm. Sci. 2014, 6(5), 121–125.
   Google Scholar
• Antonilli, L.; Brusadin, V.; Filipponi, F.; Guglielmi, R.; Nencini, P. Development and Validation of an Analytical Method Based on High Performance Thin Layer Chromatography for the Simultaneous Determination of Lamotrigine, Zonisamide and Levetiracetam in Human Plasma. J. Pharm. Biomed. Anal. 2011, 56(4), 763–770.
   PubMed Web of Science ®Google Scholar
• Bhoite, D. S.; Dhole, S. N.; Bhoir, S.; Sangole, P.; Thorat, S. Development and Validation of Stability Indicating HPTLC Method for Determination of Oxcarbazepine in Bulk and Pharmaceutical Formulation. Int. J. Pharm. Pharm. Sci. 2013, 5(3), 3–8.
   Google Scholar
• Gandhimathi, M.; Ravi, T. Rapid HPTLC Analysis of Oxcarbazepine in Human Plasma. J. Planar Chromatogr. 2008, 21(6), 1–2.
   Web of Science ®Google Scholar
• Kumar, B. S. J.; Kumar, R. V.; Sinha, V. R. Stability Indicating HPTLC Method for the Determination of Pregabalin in Bulk and Pharmaceutical Dosage Forms. Sci. Pharm. 2013, 12(10), 376–383.
   Google Scholar
• Prasad, M. K. C.; Sagar, G. V.; Sudhakar, R. D. P. Simultaneous HPTLC Method for Estimation of Gabapentin and Pregabalin. Int. J. Pharm. Pharm. Sci. 2013, 5, 326–333.
   Google Scholar
• Shah, D. A.; Patelia, E. M.; Mori, A. Simultaneous Estimation of Pregabalin and Methylcobalamine in Pharmaceutical Formulation by HPTLC-Densitometry Method. Chromatogr. Sep. Technol. 2013, 4(2), 2–5.
   Google Scholar
• Singh, M.; Kumar, L.; Arora, P.; Mathur, S. C.; Saini, P. K.; Singh, R. M.; Singh, G. N. Development and Validation of an RP-HPLC Method for Quantitative Estimation of Eslicarbazepine Acetate in Bulk Drug and Tablets. Indian J. Pharm. Sci. 2013, 736–739.
   PubMed Web of Science ®Google Scholar
• Kallam, S. R.; Srikanth, J.; Prakash, K. V. Development and Validation of an RP-HPLC Method for Related Substance and Quantitative Estimation of Eslicarbazepine Acetate in Bulk Drug and Pharmaceutical Dosage Form. J. Pharm. Biol. Sci. 2015, 10(6), 155–162.
   Google Scholar
• Patel, D.; Seth, G. L.; Bihani, S. D. RP-HPLC Method Development and Validation for Eslicarbazepine Acetate in Api. Int. J. Adv. Res. Pharm. Bio Sci. 2012, 2(2), 84–94.
   Google Scholar
• Kumar, S. P.; Dinda, S. C. Development and Validation of a Stability Indicating RP-HPLC Method for Determination of Eslicarbazepine Acetate Tablets. Int. Res. J. Pharm. 2013, 4(5), 178–180.
   Google Scholar
• Srinivas, M.; Avupati, N. R.; Sait, S.; Mukkanti, K. Stability Indicating HPLC Method for the Determination of Eslicarbazepine Acetate and Its Impurities in Bulk and Pharmaceutical Dosage Forms. J. Liq. Chromatogr. 2012, 35, 1550–1564.
   Web of Science ®Google Scholar
• Thomas, S.; Bharti, A.; Kumar, P.; Shandilya, S.; Agarwal, A.; Biswas, S.; Bhansal, V.; Kumar, A.; Kumar, P.; Mathela, C. S. Highly Efficient, Selective, Sensitive and Stability Indicating RP-HPLC–UV Method for the Quantitative Determination of Potential Impurities and Characterization of Four Novel Impurities in Eslicarbazepine Acetate Active Pharmaceutical Ingredient by LC/ES. J. Pharm. Biomed. Anal. 2012, 61, 165–175.
   PubMed Web of Science ®Google Scholar
• Jayasimha, N.; Reddy, V. K.; Sandeep, V.; Goud, E. S. K. Development and Validation of RP-HPLC for Assay of Lacosamide Injection. World J. Pharm. Pharm. Sci. 2015, 4(2), 1067–1074.
   Google Scholar
• Nazma, S.; Yasaswini, P.; Supraja, M. S.; Vijayalakshmi, M.; Nalluri, B. N. Development and Validation of RP-HPLC Method for the Estimation of Lacosamide in Bulk and Parenteral Dosage Form. Int. J. Res. Pharm. Chem. 2015, 5(2), 355–360.
   Google Scholar
• Sreedevi, B.; Navya, B.; Santhosh, R. S.; Sandhya, M.; Anitha, R.; Ramcharan, E. Method Development and Validation of Lacosamide Drug by Using RP-HPLC. Am. J. Biol. Pharm. Res. 2015, 2(2), 105–108.
   Google Scholar
• Valarmathi, R.; Senthamarai, R.; Akilandeswari, S.; Banu, S. F.; Saratha, R. Newer Analytical Validation of Lacosamide in Bulk and Their Tablet Dosage Form by RP-HPLC. World J. Pharm. Pharm. Sci. 2015, 4(4), 1083–1091.
   Google Scholar
• Sumanth, K. S.; Babu, C. J. G.; Venkatamahesh, R.; Muneer, S.; Balaji, M. Development and Validation of RP-HPLC Method for Estimation of Lacosamide in Bulk and Its Pharmaceutical Dosage Form. Int. J. Pharm. Res. Anal. 2012, 2(1), 1–5.
   Google Scholar
• Chakravarthy, V. K.; Shankar, D. G. HPLC Method for Determination of Lacosamide in Bulk and Pharmaceutical Formulation. Rasayan J. 2011, 4(4), 744–752.
   Google Scholar
• Chakravarthy, V. K.; Shankar, D. G. HPLC Method for Determination of Lacosamide S(−) Enantiomer in Bulk and Pharmaceutical Formulation. Rasayan J. 2011, 4(4), 744–752.
   Google Scholar
• Rao, N.; Kuntamukkala, R.; Lakshetti, S. Identification and Characterization of Stress Degradants of Lacosamide by LC–MS and ESI-Q-TOF-MS/MS: Development and Validation of a Stability Indicating RP-HPLC Method. J. Pharm. Biomed. Anal. 2014, 95, 256–264.
   PubMed Web of Science ®Google Scholar
• Patil, S. N.; Kadam, A. Development and Validation of Stability Indicating RP-HPLC Method for Estimation of Lacosamide in Bulk and its Pharmaceutical Formulations. Int. J. Pharm. Sci. Rev. Res. 2014, 28(29), 164–168.
   Google Scholar
• Molleti, S.; Rao, V.; Jayaveera, K. N. Stability Indicating RP-UPLC Method for the Determination of Lacosamide and its Impurities in Bulk Drugs and its Pharmaceutical Dosage Forms. Der Pharma Chem. 2013, 5(1), 81–89.
   Google Scholar
• Raul, S. K.; Mahapatra, A. K.; Kumar, B. V. V. R.; Patnaik, A. K. Stability Indicating RP-HPLC RP Method for the Estimation of Lacosamide in Bulk and Pharmaceutical Dosage Form. J. Chem. Pharm. Res. 2013, 5(11), 732–739.
   Google Scholar
• Chhalotiya, U. K.; Bhatt, K. K.; Shah, D. A.; Baldania, S. L.; Patel, J. R. Stability-Indicating Liquid Chromatographic Method for Quantification of New Anti-Epileptic Drug Lacosamide in Bulk and Pharmaceutical Formulation. Chem. Ind. Chem. Eng. Q. 2012, 18(1), 35–42.
   Web of Science ®Google Scholar
• Chakravarthy, V. K.; Sankar, D. G. Stability Indicating HPLC Method for Determination of Lacosamide and Its Degradation/impurities in Bulk and Pharmaceutical Formulation. Rasayan J. 2012, 5(3), 293–310.
   Google Scholar
• Shah, S.; Vasantharaju, S. G.; Karthik, A.; Muddukrishna, B. S. Development and Validation of Stability-Indicating Assay Method for Lacosamide by RP-HPLC. Elixir Int. J. 2011, 38, 4174–4177.
   Google Scholar
• Sreenivasulu, V.; Rao, D. R.; Bn, U. M.; Das, S. K. Development and Validation of a Stability-Indicating RP-HPLC Method for Determination of Lacosamide. Res. J. Pharm. Biol. Chem. Sci. 2011, 2(4), 1–11.
   Google Scholar
• Mahesh, H. R. K.; Babu, S. K. Quantitative Estimation of Related Compounds of Lacosamide in Oral Solution by Using Reverse Phase HPLC. Der Pharm. Lett. 2015, 7(1), 285–291.
   Google Scholar
• Ks, N.; Kb, V.; Dvns, R.; Pande, R. A Stability-Indicating Liquid Chromatographic Method for the Quantification of New Anti-Epileptic Drug Lacosamide and Its Intermediates. Int. J. Pharm. Res. Sch. 2012, 1(3), 40–47.
   Google Scholar
• Ravisankar, P.; Niharika, A.; Srinivasa, B. P. An Improved RP-HPLC Method for the Quatitative Determination and Validation of Levetiracetam in Bulk and Pharmaceutical Formulation. Int. Res. J. Pharm. 2015, 6(8), 537–543.
   Google Scholar
• Nagaraju, P.; Priyadarshini, G. I.; Appaji, S. Development and Validation of Novel HPLC Method for Estimation of Levetiracetam in Pharmaceutical Formulations. Int. J. Pharm. Chem. Sci. 2014, 3(2), 522–527.
   Google Scholar
• Saikrishna, K.; Bikshapathi1, D. V. R. N.; Kumar, U. A.; Sabitha, G.; Saikumar, B. New RP-HPLC Method for the Determination of Levetiracetam in Bulk and Prepared Tablets. Asian J. Biochem. Pharm. Res. 2011, 1(3), 294–301.
   Google Scholar
• Poongothai, S.; Balaji, V.; Madhavi, B.; Reddy, A. R.; Ilavarasan, R.; Karrunakaran, C. M. A Sensitive Dissolution Test Method for the Development and Validation of Levetiracetam Tablets by Reverse Phase-HPLC Technique. Int. J. PharmTech Res. 2011, 3(2), 1023–1032.
   Google Scholar
• Gopalakrishnan, S.; Jeyashree, B.; Ramalakshmi, A.; Chenthilnathan, A. Analytical Method Development and Validation for the Determination of Levetiracetam in Pharmaceutical Formulations by Using RP-HPLC. Der. Pharm. Lett. 2011, 3(3), 194–201.
   Google Scholar
• Usman, M.; Bibi, H.; Khalil, M. T.; Hussain, A.; Siddiqua, A.; Iqbal, J. Estimation of Levetiracetam in Bulk and Pharmaceutical Dosage Form with a Newly Developed and Validated RP-HPLC Method. Res. J. Recent Sci. 2013, 2(5), 68–70.
   Google Scholar
• Al Masud, A.; Arefeen, Md. S.; Islam, M. K.; Hasan, M. Development and Validation of a RP-HPLC Method for the Estimation of Levetiracetam in Bulk and Pharmaceutical Formulation. J. Chem. Pharm. Res. 2011, 3(1), 324–329.
   Google Scholar
• Oláh, E.; Bacso’i, Gy.; Fekete, J.; Sharma, V. K. Determination of ng/mL Levetiracetam Using Ultra-High-Performance Liquid Chromatography–Photodiode Absorbance. J. Chromatogr. Sci. 2012, 50, 253–258.
   PubMed Web of Science ®Google Scholar
• Devanaboyina, N.; Satyanarayana, T.; Rao, B. G. A Novel RP-HPLC Method for the Analysis of Levetiracetam in Formulations. Der Pharma Chem. 2011, 3(6), 112–117.
   Google Scholar
• Can, N. O.; Arli, G. Reversed-Phase HPLC Analysis of Levetiracetam in Tablets Using Monolithic and Conventional C18 Silica Columns. J. AOAC Int. 2010, 93(4), 1077–1086.
   PubMed Web of Science ®Google Scholar
• Rao, A. L.; Jahnavi, V. N. A Validated RP-HPLC Method for the Estimation of Levetiracetam in Bulk and Pharmaceutical Formulations. E-Journal Chem. 2010, 7(2), 600–604.
   Google Scholar
• Valarmathy, J.; Samueljoshua, L.; Rathinavel, G.; Thanuja, C. S.; Sivakumar, T. RP-HPLC Method Development and Validation for Assay of Levetiracetam in Tablet Dosage Form. Res. J. Pharm. Technol. 2008, 1(3), 395–397.
   Google Scholar
• Basaveswara, R. M. V.; Nagendrakumar, A. V. D.; Raman, B. V.; Malathi, R. T. Validated RP-HPLC Method for the Estimation of Levetiracetam in Tablet Formulations. J. Pharm. Res. 2012, 5(1), 75.
   Google Scholar
• Prasad, M. K. C.; Sagar, G. V.; Sudhakar, P. Stability Indicating RP HPLC Method for Determination of Levetiracetam in Pharmaceutical Formulation. Indian J. Pharm. Biol. Res. 2013, 1(4), 45–54.
   Google Scholar
• Shah, J. S.; Vidyasagar, G.; Barot, H. Stability Indicating RP-HPLC Method for Estimation of Levetiracetam in Pharmaceutical Formulation and Application to Pharmacokinetic Study. Der. Pharm. Sin. 2012, 3(5), 576–589.
   Google Scholar
• Žirojevi, J.; Drljevic-Đurić, K.; Đurđević, A. Determination of Oxcarbazepine and its Related Substances Using UHPLC Method with UV Detection. Arh. Farm. 2014, 64, 83–94.
   Google Scholar
• Raghavi, K.; Sindhura, M.; Prashanthi, R.; Nalluri, B. N. RP-HPLC–PDA Method Development and Validation for the Estimation of Oxcarbazepine in Bulk and Formulations. Acta Chromatogr. 2013, 25, 519–529.
   Web of Science ®Google Scholar
• Singh, P.; Gupta, M. K.; Kumar, C.; Bhalla, V. Development and Validation of a RP-HPLC Method for Quantitation of Oxcarbazepine in Tablet Dosage Form. Asian J. Pharm. Technol. Innov. 2015, 3(13), 1–8.
   Google Scholar
• Kundu, S.; Gyadangi, B. A. Simple, Validated, Single HPLC Method for the Determination of Assay, Dissolution, Related Substance of an Antiepileptic Drug in Different Pharmaceutical Dosage Form. Indo Am. J. Pharm. Res. 2013, 3(12), 1722–1732.
   Google Scholar
• Dwivedi, P.; Yadav, S.; Rao, J. Validated RP HPLC Method for the Determination of Related Substance of Oxcarbazepine an Antiepileptic Drug. Int. J. PharmTech Res. 2016, 9(3), 444–451.
   Google Scholar
• Ks, R.; Belorkar, N.; Meb, R. Development and Validation of Stability-Indicating Liquid Chromatographic Method for the Quantitative Determination of Oxcarbazepine in Tablet Dosage Forms. J. Young Pharm. 2009, 1(3), 270–277.
   Google Scholar
• Raghavi, K.; Sindhura, M.; Prashanthi, R.; Nalluri, B. N. Studies on Forced Degradation of Oxcarbazepine Using LC–MS Compatible Stability Indicating RP-HPLC Method. J. Chem. Pharm. Res. 2012, 4(8), 3885–3893.
   Google Scholar
• Panda, S. S.; Venkatavaraha, B.; Kumar, R.; Panda, R. K.; Patel, K.; Nagireddy, N. R. Development and Validation of a Stability-Indicating RP-UFLC Method for Determination of Oxcarbazepine in Tablet Dosage Form. J. Adv. Pharm. Res. 2012, 3(4), 77–84.
   Google Scholar
• Bhaumik, U.; Bose, A.; Chatterjee, B.; Ghosh, A.; Sengupta, P.; Agarwal, S.; Das, A.; Pal, T. K. Stability-indicating HPLC Method for the Determination of Oxcarbazepine in Pharmaceutical Formulation. Asian J. Chem. 2010, 22, 2051–2057.
   Google Scholar
• Akther, H.; Morshed, M.; Islam, M.; Hassan, J.; Barua, B. P.; Emran, T. B. Development of a Method and its Validation for Estimation of Pregabaline in Pharmaceutical and Bulk Formulation. Biomed. Sci. Today 2015, 1–8.
   Google Scholar
• Seema, A.; Jeeja, P.; Ashish, J. Development and Validation of HPLC Method for Estimation of Pregabalin in Bulk & Capsule Dosage Form. Pharm. Anal. Acta 2016, 7(6), 1–6.
   Google Scholar
• Balaji, J.; Ramachandra, B.; Naidu, N. V. S. Analytical RP-HPLC Method for Development and Validation of Pregabalin in Bulk and the Determination of Pregabalin in Capsule Dosage Form. Int. J. Innov. Res. Sci. Eng. Technol. 2014, 3(4), 11094–11098.
   Google Scholar
• Singh, V.; Singh, R. K.; Gupta, R. K.; Swain, R.; Sahoo, J. Development and Validation of RP-HPLC Method for the Assay of Pregabalin Capsule. World J. Pharm. Pharm. Sci. 2013, 3(1), 703–711.
   Google Scholar
• Reddy, N. C. M.; Sekhar, K. B. C. RP-HPLC Determination of Related Substances of Pregabalin in Bulk and Pharmaceutical Dosage Form. Int. J. Chem. Pharm. Sci. 2012, 2012, 3(2), 40–46.
   Google Scholar
• Bammidi, E. R.; Lakinani, V.; Lanka, S. Method Development and Validation Studies of Pregabalin Drug by RP-HPLC Method. J. Pharm. Biomed. Anal. Lett. 2015, 3(1), 214–217.
   Google Scholar
• Jadhav, A. S.; Pathare, D. B.; Shingare, M. S. Validated Enantioselective LC Method, with Precolumn Derivatization with Marfey’s Reagent, for Analysis of the Antiepileptic Drug Pregabalin in Bulk Drug Samples. Chromatographia 2007, 65, 253–256.
   Web of Science ®Google Scholar
• Chen, X.; Zhang, D.; Deng, J.; Fu, X. Determination of Optical Impurity of Pregabalin by HPLC with Pre-Column Chiral Derivatization. J. Chromatogr. Sci. 2008, 46, 42–44.
   PubMed Web of Science ®Google Scholar
• Martinc, B.; Grabnar, I.; Mrhar, A.; Vovk, T. Rapid High-Performance Liquid Chromatography Method for Determination of Pregabalin in a Pharmaceutical Dosage Form Following Derivatization with Fluorescamine. J. AOAC Int. 2010, 93(4), 1069–1076.
   PubMed Web of Science ®Google Scholar
• Doŭ, M.; Gibala, P.; Lemr, K. Liquid Chromatographic Separation of Pregabalin and Its Possible Impurities with Fluorescence Detection after Postcolumn Derivatization with O-Phtaldialdehyde. J. Pharm. Biomed. Anal. 2010, 53, 717–722.
   Google Scholar
• Vukkum, P.; Babu, J. M.; Muralikrishna, R. Stress Degradation Behavior of Pregabalin, Identification of Degradation Impurities and Development of Stability Indicating UPLC Method. Int. J. Pharm. Sci. Res. 2015, 6(6), 2241–2257.
   Google Scholar
• Mishra, S. M.; Gurupadhyya, B. M.; Verma, S. Stability Indicating RP-HPLC Method for Determination of Pregabalin Using ICH Guidelines. Int. J. Nat. Prod. Sci. 2012, 115(1), 2012.
   Google Scholar
• Sneha, P.; Srinivas, P. Stability Indicating Assay Method Development and Validation of Pregabalin in Pharmaceutical Dosage Forms by RP-HPLC. Indo Am. J. Pharm. Sci. 2015, 2(6), 1038–1047.
   Google Scholar
• Ravisankar, P.; Lokapavani, C. H.; Devadasu, C. H.; Rao, G. D. An Improved RP-HPLC Method for the Quantitative Determination and Validation of Retigabine in Bulk and Pharmaceutical Formulation. Int. J. Res. Pharm. Sci. 2014, 4(4), 21–26.
   Google Scholar
• Lakshmi, B.; Saraswathi, K.; Reddy, T. RP-HPLC Method Development and Validation for the Analysis of Ezogabine in Pharmaceutical Dosage Forms. Int. J. Res. Pharm. Biomed. Sci. 2012, 3(4), 1483–1487.
   Google Scholar
• Satyanarayana, P. V. V.; Madhavi, A. S. Validated RP-HPLC Method for the Estimation of Ezogabine in Tablet Dosage Form. Int. J. Res. Pharm. Biomed. Sci. 2012, 3(2), 1261–1265.
   Google Scholar
• Wang, X.; Zhou, H.; Zheng, J.; Huang, C.; Liu, W.; Yu, L.; Zeng, S. Identification and Characterization of Four Process-Related Impurities in Retigabine. J. Pharm. Biomed. Anal. 2012, 71, 148–151.
   PubMed Web of Science ®Google Scholar
• Chhabda, P. J.; Balaji, M.; Srinivasarao, V. Development and Validation of a Simple and Stability Indicating LC Method for Analysis of Ezogabine in Bulk Drug and Pharmaceutical Dosage Form. J. Sci. Res. Pharm 2013, 2(4), 1–6.
   Google Scholar
• Wu, X.; Shao, F.; Tao, C.; Li, J. Development and Validation of a Stability Indicating HPLC Method for the Determination of Retigabine and Its Related Substances in Drug Substances. J. Chinese Pharm. Sci. 2015, 24(4), 241–249.
   Google Scholar
• Tamilselvi, N.; Rajasekaran, A. Stability-Indicating RP-HPLC Method for the Determination of Ezogabine and Identification of Its Degradation Products. J. Pharm. Sci. Res. 2016, 8(1), 19–23.
   Google Scholar
• Siddiqui, S.; Vani, R.; Khan, D. Bioanalytical Method Development and Validation of Lacosamide in Rat Serum Using HPLC. World J. Pharm. Res. 2014, 3(12), 1064–1072.
   Google Scholar
• Devi, M. S.; Varma, D. P.; Rani, G. T.; Srinivas, N. Liquid Chromatographic Assay of Lacosamide in Human Plasma Using Liquid–Liquid Extraction. Int. J. Pharm. Pharm. Sci. 2014, 6(1), 530–533.
   Google Scholar
• Payto, D. Liquid Chromatography-Tandem Mass Spectrometry for Measurement of Serum Lacosamide and Desmethyl Lacosamide. Clevel. Clin. 2010, 50(3), 444–445.
   Google Scholar
• Mohammadi, B.; Majnooni, M.; Afnanzade, N.; Bahrami, G. Simple and Rapid Ultra High Performance Liquid Chromatographic (UHPLC) Method for the Determination of Levetiracetam in Human Serum: Application to a Bioequivalence Study. African J. Pharm. Pharmacol. 2012, 6(27), 2017–2022.
   Web of Science ®Google Scholar
• Tyagi, M. G.; Kannan, S.; Manickam, A. S.; Chander, J. S. J. U. A Novel HPLC Estimation Technique for the Anti-Epileptic Drug Levetiracetam in Tablet and Human Urine Samples. World J. Pharm. Sci. 2015, 4(6), 1093–1099.
   Google Scholar
• Hadad, G. M.; Abdel Salam, R. A.; Abdel Hameed, E. A. Quantitative Determination of Levetiracetam in Human Urine Using HPLC–UV and its Identification by LC–ESI–MS. J. Liq. Chromatogr. Relat. Technol. 2013, 36(18), 2568–2579.
   Web of Science ®Google Scholar
• Matar, K. M. Quantification of Levetiracetam in Human Plasma by Liquid Chromatography–Tandem Mass Spectrometry: Application to Therapeutic Drug Monitoring. J. Pharm. Biomed. Anal. 2008, 48, 822–828.
   PubMed Web of Science ®Google Scholar
• Guo, T.; Oswald, L. M.; Rao, D.; Soldin, S. J. Determination of Levetiracetam in Human Plasma/Serum/Saliva by Liquid Chromatography–Electrospray Tandem Mass Spectrometry. Clin. Chim. Acta 2007, 375, 115–118.
   PubMed Web of Science ®Google Scholar
• Blonk, M. I.; Nagel, B. C. V. D.; Smit, L. S.; Mathot, R. A. A. Quantification of Levetiracetam in Plasma of Neonates by Ultra Performance Liquid Chromatography–Tandem Mass Spectrometry. J. Chromatogr. B 2010, 878, 675–681.
   PubMed Web of Science ®Google Scholar
• Naidu, Y. K.; Reddy, R. S.; Divi, K. R.; Reddy, M. P. K.; Chandiran, I. S.; Jayaveera, K. N. Quantification of Levetiracetam in Human Plasma with Precipitation Extraction by Using Fully Validated LC-MS / MS and its Application to a Bioequivalence Study. Res. J. Pharm. Technol. 2010, 3(3), 847–852.
   Google Scholar
• Yeap, L.; Lo, Y. Rapid and Simultaneous Quantification of Levetiracetam and Its Carboxylic Metabolite in Human Plasma by Liquid Chromatogrphy Tandem Mass Spectrometry. PLoS One 2014, 9(11), 1–9.
   Web of Science ®Google Scholar
• Rao, D.; Soldin, S. J. Simultaneous Determination of Levetiracetam and Its Acid Metabolite (UCB L057) in Serum/Plasma by Liquid Chromatography Tandem Mass Spectrometry. Clin. Biochem. 2010, 43, 485–489.
   PubMed Web of Science ®Google Scholar
• Ramprasad, M. V. N. S.; Sundar, B. S. Development and Validation of High Performance Liquid Chromatographic Method for the Determination of Levetiracetam in Human Plasma by Electospray Ionization-Mass Spectrometry. Int. J. Sci. Eng. Res. 2014, 5(3), 602–609.
   Google Scholar
• Sarmiento, L. A. Levetiracetam Determination in Serum by HPLC–UV. Rev. Med 2014, 22(1), 12–19.
   Google Scholar
• Ganesan, M.; Rauthan, S. K.; Yadav, S. S.; Pandey, Y.; Tripathi, P. Validated Liquid Chromatographic Ultra Violet Method for the Quantization of Levetiracetam in Human Plasma Using Liquid–Liquid Extraction. Int. J. Pharm. Sci. Rev. Res. 2010, 1(1), 1–9.
   Google Scholar
• Pucci, V.; Bugamelli, F.; Mandrioli, R.; Ferranti, A.; Kenndler, E.; Raggi, M. A. High-Performance Liquid Chromatographic Determination of Levetiracetam in Human Plasma: Comparison of Different Sample Clean-up Procedures. Biomed. Chromatogr. 2004, 18, 37–44.
   PubMed Web of Science ®Google Scholar
• Lobenhoffer, J. M.; Bode-Böger, S. M. Determination of Levetiracetam in Human Plasma with Minimal Sample Pretreatment. J. Chromatogr. B 2005, 819, 197–200.
   PubMed Web of Science ®Google Scholar
• Bhatt, M.; Shah, S. Rapid Ultraperformance Liquid Chromatography–Tandem Mass Spectrometry Method for Quantification of Oxcarbazepine and Its Metabolite in Human Plasma. Biomed. Chromatogr. 2011, 2010, 751–759.
   Web of Science ®Google Scholar
• Ahmadkhaniha, R.; Mottaghi, S.; Zargarpoor, M.; Souri, E. Validated HPLC Method for Quantification of Pregabalin in Human Plasma Using 1-Fluoro-2,4-Dinitrobenzene as Derivatization Agent. Chromatogr. Res. Int. 2014, 2014, 1–6.
   Google Scholar
• Gujral, R. S.; Haque, S. M.; Kumar, S. A Novel Method for the Determination of Pregabalin in Bulk Pharmaceutical Formulations and Human Urine Samples. African J. Pharm. Pharmacol. 2009, 3(6), 327–334.
   Web of Science ®Google Scholar
• Uma, G.; Manimala, M.; Vasudevan, M.; Karpagam, S.; Deecarman. LC–MS–MS Method for the Determination of Pregabalin in Human Plasma. Int. J. Pharm. Pharm. Sci. 2012, 4(3), 2–6.
   Google Scholar
• Pauly, C.; Yegles, M.; Schneider, S. Pregabalin Determination in Hair by Ultra-High-Performance Liquid Chromatography–Tandem Mass Spectrometry. J. Anal. Toxicol. 2013, 37, 676–679.
   PubMed Web of Science ®Google Scholar
• Knebel, N. G.; Grieb, S.; Leisenheimer, S.; Locher, M. Determination of Retigabine and its Acetyl Metabolite in Biological Matrices by on-Line Solid-Phase Extraction (Column Switching) Liquid Chromatography with Tandem Mass Spectrometry. J. Chromatogr. B 2000, 748, 2006.
   Web of Science ®Google Scholar
• Loureiro, A. I.; Fernandes-lopes, C.; Wright, L. C.; Soares-da-silva, P. Development and Validation of an Enantioselective Liquid-Chromatography/Tandem Mass Spectrometry Method for the Separation and Quantification of Eslicarbazepine Acetate, Eslicarbazepine, R-Licarbazepine and Oxcarbazepine in Human Plasma. J. Chromatogr. B 2011, 879(25), 2611–2618.
   PubMed Web of Science ®Google Scholar
• Alves, G.; Figueiredo, I.; Castel-branco, M.; Loureiro, A.; Fortuna, A.; Falcão, A.; Caramona, M. Enantioselective HPLC-UV Method for Determination of Eslicarbazepine Acetate (BIA 2–093) and Its Metabolites in Human Plasma. Biomed. Chromatogr. 2007, 1134, 1127–1134.
   Web of Science ®Google Scholar
• Fortuna, A.; Bicker, J.; Alves, G.; Falcao, A.; Soares-da-Silva, P. Chiral HPLC–UV Method for the Quantification of Dibenz (b,f) Azepine-5-Carboxamide Derivatives in Mouse Plasma and Brain Tissue: Eslicarbazepine Acetate, Carbamazepine and Main Metabolites. J. Sep. Sci. 2011, 1391–1401.
   PubMed Web of Science ®Google Scholar
• Alves, G.; Figueiredo, I.; Castel-branco, M.; Loureiro, A. Simultaneous and Enantioselective Liquid Chromatographic Determination of Eslicarbazepine Acetate, S-Licarbazepine, R-Licarbazepine and Oxcarbazepine in Mouse Tissue Samples Using Ultraviolet Detection. Anal. Chim. Acta 2007, 596, 132–140.
   PubMed Web of Science ®Google Scholar
• Fortuna, A.; Sousa, J.; Alves, G.; Falcão, A.; Soares-da-silva, P. Development and Validation of an HPLC-UV Method for the Simultaneous Quantification of Carbamazepine, Oxcarbazepine, Eslicarbazepine Acetate and Their Main Metabolites in Human Plasma. Anal. Bioanal. Chem. 2010, 397, 1605–1615.
   PubMed Web of Science ®Google Scholar
• Juenke, J. M.; Brown, P. I.; Thomas, R. L.; Davis, K. L. J. Application of Ultra High-Performance Liquid Chromatography Tandem Mass Spectrometry for the Analysis of Lacosamide and Metabolite Des-Lacosamide, Rufinamide, and Felbamate in Serum and Plasma. ARUP Inst. Clin. Exp. Pathol. 2010, 2, 1–2.
   Google Scholar
• Kuhn, J.; Knabbe, C. Fully Validated Method for Rapid and Simultaneous Measurement of Six Antiepileptic Drugs in Serum and Plasma Using Ultra-Performance Liquid Chromatography–Electrospray Ionization Tandem Mass Spectrometry. Talanta 2013, 110, 71–80.
   PubMed Web of Science ®Google Scholar
• Juenke, J. M.; Brown, P. I.; Johnson-davis, K. L.; Mcmillin, G. A. Simultaneous Quantification of Levetiracetam and Gabapentin in Plasma by Ultra-Pressure Liquid Chromatography Coupled with Tandem Mass Spectrometry Detection. Drug Monit. 2011, 33(2), 209–213.
   PubMed Web of Science ®Google Scholar
• Siddiqui, F. A.; Sher, N.; Shafi, N.; Sial, A. W.; Ahmad, M.; Naseem, H. Development of New Method for Simultaneous Analysis of Piracetam and Levetiracetam in Pharmaceuticals and Biological Fluids: Application in Stability Studies. Biomed Res. Int. 2014, 2014, 1–8.
   Web of Science ®Google Scholar
• Baldelli, S.; Cattaneo, D.; Giodini, L.; Baietto, L.; Di Perri, G.; D’Avolio, A.; Clementi, E. Development and Validation of a HPLC–UV Method for the Quantification of Antiepileptic Drugs in Dried Plasma Spots. Clin. Chem. Lab. Med. 2015, 53(3), 435–444.
   PubMed Web of Science ®Google Scholar
• Kim, K. B.; Seo, K. A.; Kim, S. E.; Bae, S. K.; Kim, D. H.; Shin, J. G. Simple and Accurate Quantitative Analysis of Ten Antiepileptic Drugs in Human Plasma by Liquid Chromatography/tandem Mass Spectrometry. J. Pharm. Biomed. Anal. 2011, 56(4), 771–777.
   PubMed Web of Science ®Google Scholar
• Zhu, X.; Zhao, Y.; Cheng, Z.; Zhao, N. M.; Li, H. The Establish of the HPLC Method to Examine the Plasma Concentration of Lamotrigine and Oxcarbazepine. Pak. J. Pharm. Sci. 2015, 28(3), 1121–1125.
   PubMed Web of Science ®Google Scholar
• Serralheiro, A.; Alves, G.; Fortuna, A.; Falcão, A. Fast HPLC-UV Method for the Simultaneous Determination of Carbamazepine, Lamotrigine, Oxcarbazepine and Phenytoin in Mouse Plasma, Brain and Liver Tissues. Cent. Neurosci. Cell Biol. 2011, 397, 397–398.
   Google Scholar
• Suganya, S.; Bright, A.; Devi, T. S. R. Studies on Linearity and Assay Using RP-HPLC and UV–Visible Spectroscopy for the Drugs Oxcarbazepine and Pioglitazone Before and After Expiry Period. Int. J. Pharm. Sci. Res. 2012, 3(6), 1731–1734.
   Google Scholar
• Fortuna, A.; Sousa, J.; Alves, G.; Falcão, A.; Soares-da-silva, P. Development and Validation of an HPLC–UV Method for the Simultaneous Quantification of Carbamazepine, Oxcarbazepine, Eslicarbazepine Acetate and their Main Metabolites in Human Plasma. Anal Bioanal Chem 2010, 397, 1605–1615.
   PubMed Web of Science ®Google Scholar
• Greiner-sosanko, E.; Giannoutsos, S.; Lower, D. R.; Virji, M. A.; Krasowski, M. D. Drug Monitoring: Simultaneous Analysis of Lamotrigine, Oxcarbazepine, 10-Hydroxycarbazepine, and Zonisamide by HPLC–UV and a Rapid GC Method Using a Nitrogen–Phosphorus Detector for Levetiracetam. J. Chromatogr. Sci. 2008, 45(9), 616–622.
   Web of Science ®Google Scholar
• Ma, C. L.; Jiao, Z.; Jie, Y.; Shi, X. J. Isocratic Reversed-Phase HPLC for Simultaneous Separation and Determination of Seven Antiepileptic Drugs and Two of their Active Metabolites in Human Plasma. Chromatographia 2007, 65(5–6), 267–275.
   Web of Science ®Google Scholar
• Bhavsar, A.; Shah, D.; Solanki, T.; Sevak, N.; Ajmeer, R. Development and Validation of RP-HPLC Method for Simultaneous Estimation of Aceclofenc and Pregabalin in Combined Tablet Dosage Form. Pharm. Biol. Eval. 2015, 2(4), 91–97.
   Google Scholar
• Manasa, M.; Swapna, G.; Prakash, S.; Swapna, G. RP-HPLC Method for Simultaneous Estimation of Pregabalin and Tapentadol in Bulk and Pharmaceutical Dosage Form. Asian J. Biomed. Pharm. Sci. 2014, 4(36), 63–66.
   Google Scholar
• Mohan, J. A.; Kumar, A. A. RP-HPLC Method Development and Validation for the Simultaneous Quantitative Estimation of Pregabalin, Mecobalamin and Alpha Lipoic Acid in Capsules. Int. J. Pharm. Pharm. Sci. 2014, 6(1), 2–9.
   Google Scholar
• Kk, B.; Patelia, E. M.; Mori, A. Simultaneous Estimation of Pregabalin and Methylcobalamine in Pharmaceutical Formulation by RP-HPLC Method. Anal. Bioanal. Tech. 2013, 4(1), 10–13.
   Google Scholar
• Kannapan, N.; Nayak, S. P.; Venkatachalam, T.; Prabhakaran, V. Analytical RP-HPLC Method for Development and Validation of Pregabalin and Methylcobalamine in Combined Capsule Formulation. J. Appl. Chem. Res. 2010, 13, 85–89.
   Google Scholar
• Narmada, P.; Vijaya, L. G.; Nalini, G.; Gowtham, Y.; Suhasini, B.; Jogi, K. V. RP-HPLC Method Development and Validation for the Determination of Methylcobalamin and Pregabalin in Combined Capsule Dosage Form. Int. J. Res. Pharm. Sci. 2013, 4(1), 25–29.
   Google Scholar
• Pola, L. M.; Sankar, D. G. Validated Stability Indicating RP-LC Method for Simultaneous Quantitative Estimation of Aceclofenac and Pregabalin in Bulk Drug and Combined Tablet Dosage Form. Int. J. Pharm. Biomed. Res. 2014, 5(4), 78–84.
   Google Scholar
• Dzygiel, P.; Fraier, D. Simultaneous Determination of Pregabalin, Sildenafil and its Active Metabolite in Rat Plasma Utilising SPE Followed by LC–MS–MS. Chromatographia 2011, 73, 1177–1182.
   Web of Science ®Google Scholar
• Kostić, N.; Dotsikas, Y.; Malenović, A.; Stojanović, B. J.; Rakić, T.; Ivanović, D.; Medenica, M. Stepwise Optimization Approach for Improving LC–MS/MS Analysis of Zwitterionic Antiepileptic Drugs with Implementation of Experimental Design. J. Mass Spectrom. 2013, 48(7), 875–884.
   PubMed Web of Science ®Google Scholar
• Deeb, S.; McKeown, D. A.; Torrance, H. J.; Wylie, F. M.; Logan, B. K.; Scott, K. S. Simultaneous Analysis of 22 Antiepileptic Drugs in Postmortem Blood, Serum and Plasma Using LC–MS–MS with a Focus on Their Role in Forensic Cases. J. Anal. Toxicol. 2014, 38(8), 485–494.
   PubMed Web of Science ®Google Scholar
• Nikolaou, P.; Papoutsis, I.; Spiliopoulou, C.; Voudris, C.; Athanaselis, S. A Fully Validated Method for the Determination of Lacosamide in Human Plasma Using Gas Chromatography with Mass Spectrometry: Application for Therapeutic Drug Monitoring. J. Sep. Sci. 2015, 38(2), 260–266.
   PubMed Web of Science ®Google Scholar
• GE, V. E.; Wd, P. Gas Chromatographic Assay for Oxcarbazepine and its Main Metabolites in Plasma. J. Chromatogr. 1985, 67–76.
   Google Scholar
• Krishna, M.; Mudiam, R.; Chauhan, A.; Jain, R.; Ch, R.; Fatima, G.; Malhotra, E.; Murthy, R. C. Development, Validation and Comparison of Two Microextraction Techniques for the Rapid and Sensitive Determination of Pregabalin in Urine and Pharmaceutical Formulations after Ethyl Chloroformate Derivatization Followed by Gas Chromatography–Mass Spectrom. J. Pharm. Biomed. Anal. 2012, 70, 310–319.
   PubMed Web of Science ®Google Scholar
• Shihabi, Z. K.; Oles, K.; Hinsdale, M. Analysis of the Antiepileptic Drug Keppra by Capillary Electrophoresis. J. Chromatogr. A 2003, 1004, 9–12.
   PubMed Web of Science ®Google Scholar
• Ivanova, M.; Piunti, A.; Marziali, E.; Komarova, N.; Raggi, M. A.; Kenndler, E. Microemulsion Electrokinetic Chromatography Applied for Separation of Levetiracetam from Other Antiepileptic Drugs in Polypharmacy. Electrophoresis 2003, 24, 992–998.
   PubMed Web of Science ®Google Scholar
• Rodr, J.; Casta, G.; Mu, L. Direct Determination of Pregabalin in Human Urine by Nonaqueous CE-TOF-MS. Electrophoresis 2013, 34, 1429–1436.
   PubMed Web of Science ®Google Scholar